The 5-year estimated probability cumulative survival rate was also different in both group patients with BRCA1– CRC or ERCC1– CRC than in the ERCC1+/BRCA1+ group (P < 0.05). The gene discussed is ERCC1; the disease is colorectal carcinoma.